Dun & Bradstreet Reports Third Quarter 2021 Financial Results
Dun & Bradstreet Holdings, Inc. (NYSE: DNB) reported strong unaudited financial results for Q3 2021. GAAP Revenue reached $541.9 million, up 21.9% year-over-year. Adjusted net income surged to $123.4 million, translating to adjusted EPS of $0.29. Organic revenue growth was noted at 4%, with notable contributions from both North America and International segments. Total debt stood at $3.66 billion, but the company has reaffirmed its full-year revenue guidance of $2.145 to $2.175 billion and adjusted EBITDA of $840 to $855 million, while increasing its adjusted EPS outlook to $1.06 to $1.09.
- GAAP Revenue grew 21.9% YoY, hitting $541.9 million.
- Adjusted net income increased 22% YoY to $123.4 million.
- Organic revenue growth accelerated to 4% in Q3 2021.
- Increased full-year adjusted EPS guidance to $1.06 to $1.09.
- Net loss for the nine months was $60.1 million, although improved from a loss of $182.4 million year-over-year.
-
GAAP Revenue and Adjusted Revenue for the third quarter of 2021 were
, an increase of$541.9 million 21.9% and22.0% on a constant currency basis compared to the third quarter of 2020, which includes the net impact of lower deferred revenue purchase accounting adjustments of .$1.0 million
-
Excluding the net impact of the
Bisnode acquisition, organic revenue, before the effect of foreign exchange, was , an increase of$462.5 million 3.9% compared to third quarter of 2020, which also included a 0.2 percentage point impact from the net impact of lower deferred revenue purchase accounting adjustments of .$1.0 million
-
Net income for the third quarter of 2021 was
, or diluted earnings per share of$16.6 million , compared to a net loss of$0.04 or diluted loss per share of$16.3 million for the prior year quarter. Adjusted net income was$0.04 , or adjusted diluted earnings per share of$123.4 million , compared to adjusted net income of$0.29 , or adjusted diluted earnings per share of$101.2 million for the prior year quarter.$0.24
-
Adjusted EBITDA for the third quarter of 2021 was
, up$220.4 million 12.3% compared to the third quarter of 2020, and adjusted EBITDA margin was40.7% , which included the net impact of lower deferred revenue purchase accounting adjustments of .$1.0 million
“In the third quarter, we accelerated organic growth to 4 percent. We continue to execute against our playbook and focus innovation to capture tailwinds in rapidly growing areas. We have set the stage for a strong finish to 2021 and increasing momentum into 2022, through investment in new product development, extended offerings through strategic partnerships and expanded capabilities via acquisition. We continue to leverage our core strengths both domestically and internationally and are very pleased with the continued progress we have made to date,” said
-
GAAP Revenue for the nine months ended
September 30, 2021 was , an increase of$1,567.3 million 24.5% and23.8% on a constant currency basis compared to the nine months endedSeptember 30, 2020 , which includes the net impact of lower deferred revenue purchase accounting adjustments of .$20.3 million
-
Adjusted Revenue for the nine months ended
September 30, 2021 was , an increase of$1,571.9 million 24.9% and24.2% on a constant currency basis compared to the nine months endedSeptember 30, 2020 . Excluding the net impact of theBisnode acquisition, organic revenue, before the effect of foreign exchange, was , an increase of$1,318.2 million 4.3% compared to the nine months endedSeptember 30, 2020 , which also included a 1.7 percentage point impact from the net impact of lower deferred revenue purchase accounting adjustments of .$20.3 million
-
Net loss for the nine months ended
September 30, 2021 was , or diluted loss per share of$60.1 million , compared to a net loss of$0.14 , or diluted loss per share of$182.4 million for the prior year period. Adjusted net income was$0.52 , or adjusted diluted earnings per share of$329.2 million , compared to adjusted net income of$0.77 , or adjusted diluted earnings per share of$231.9 million for the prior year period.$0.67
-
Adjusted EBITDA for the nine months ended
September 30, 2021 was , up$604.4 million 19.1% compared to the nine months endedSeptember 30, 2020 , and adjusted EBITDA margin was38.5% , which included the net impact of lower deferred revenue purchase accounting adjustments of .$20.3 million
Segment Results
For the third quarter of 2021,
-
Finance and Risk revenue for the third quarter of 2021 was
, an increase of$214.0 million or$7.4 million 3.6% and3.4% on a constant currency basis compared to the third quarter of 2020.
-
Sales and Marketing revenue for the third quarter of 2021 was
, an increase of$160.1 million or$3.7 million 2.3% both after the effect of foreign currency and on a constant currency basis compared to the third quarter of 2020.
For the nine months ended
-
Finance and Risk revenue for the nine months ended
September 30, 2021 was , an increase of$604.2 million or$11.0 million 1.9% and1.6% on a constant currency basis compared to the nine months endedSeptember 30, 2020 .
-
Sales and Marketing revenue for the nine months ended
September 30, 2021 was , an increase of$466.5 million or$0.8 million 0.2% and0.1% on a constant currency basis compared to the nine months endedSeptember 30, 2020 .
International
International revenue for the third quarter of 2021 was
-
Finance and Risk revenue for the third quarter of 2021 was
, an increase of$108.7 million or$41.1 million 60.8% and60.7% on a constant currency basis compared to the third quarter of 2020. Organic revenue before the effect of foreign exchange increased1.8% .
-
Sales and Marketing revenue for the third quarter of 2021 was
, an increase of$59.1 million or$44.3 million 299.9% and306.5% on a constant currency basis compared to the third quarter of 2020. Organic revenue before the effect of foreign exchange increased21.7% .
International adjusted EBITDA was
International revenue for the nine months ended
-
Finance and Risk revenue for the nine months ended
September 30, 2021 was , an increase of$320.1 million or$139.8 million 77.6% and73.6% on a constant currency basis compared to the nine months endedSeptember 30, 2020 . Organic revenue before the effect of foreign exchange increased6.2% .
-
Sales and Marketing revenue for the nine months ended
September 30, 2021 was , an increase of$181.3 million or$141.2 million 352.2% and345.6% on a constant currency basis compared to the nine months endedSeptember 30, 2020 . Organic revenue before the effect of foreign exchange increased20.6% .
International adjusted EBITDA was
Balance Sheet
As of
Business Outlook
-
Adjusted Revenues are expected to be in the range of
to$2,145 million .$2,175 million
-
Adjusted EBITDA is expected to be in the range of
to$840 million .$855 million
-
Adjusted EPS is expected to be in the range of
to$1.06 , versus prior guidance for the high end of the range of$1.09 to$1.02 .$1.06
The foregoing forward-looking statements reflect Dun & Bradstreet’s expectations as of today's date and Revenue assumes constant foreign currency rates.
Earnings Conference Call and Audio Webcast
The call will also be webcast live from Dun & Bradstreet’s investor relations website at https://investor.dnb.com. Following the completion of the call, a recorded replay of the webcast will be available on the website.
About
Use of Non-GAAP Financial Measures
In addition to reporting GAAP results, we evaluate performance and report our results on the non-GAAP financial measures discussed below. We believe that the presentation of these non-GAAP measures provides useful information to investors and rating agencies regarding our results, operating trends and performance between periods. These non-GAAP financial measures include adjusted revenue, organic revenue, adjusted earnings before interest, taxes, depreciation and amortization (‘‘adjusted EBITDA’’), adjusted EBITDA margin, adjusted net income and adjusted net earnings per diluted share. Adjusted results are non-GAAP measures that adjust for the impact due to purchase accounting application and divestitures, restructuring charges, equity-based compensation, acquisition and divestiture-related costs (such as costs for bankers, legal fees, due diligence, retention payments and contingent consideration adjustments) and other non-core gains and charges that are not in the normal course of our business (such as gains and losses on sales of businesses, impairment charges, effect of significant changes in tax laws and material tax and legal settlements). We exclude amortization of recognized intangible assets resulting from the application of purchase accounting because it is non-cash and not indicative of our ongoing and underlying operating performance. Recognized intangible assets arise from acquisitions, or primarily the Take-Private Transaction (refer to Note 5 to the condensed consolidated financial statements for the three and nine months ended
Our non-GAAP or adjusted financial measures reflect adjustments based on the following items, as well as the related income tax.
Adjusted Revenue
We define adjusted revenue as revenue adjusted to include a revenue adjustment due to the timing of the completion of the
Organic Revenue
We define organic revenue as adjusted revenue before the effect of foreign exchange excluding revenue from the acquired company for the first twelve months. We believe the organic measure provides investors and analysts with useful supplemental information regarding the Company’s underlying revenue trends by excluding the impact of acquisitions.
Adjusted EBITDA and Adjusted EBITDA Margin
We define adjusted EBITDA as net income (loss) attributable to
- depreciation and amortization;
- interest expense and income;
- income tax benefit or provision;
- other expenses or income;
- equity in net income of affiliates;
- net income attributable to non-controlling interests;
- dividends allocated to preferred stockholders;
- other incremental or reduced expenses and revenue from the application of purchase accounting (e.g. commission asset amortization) and acquisitions;
- equity-based compensation;
- restructuring charges;
- merger and acquisition-related operating costs;
- transition costs primarily consisting of non-recurring incentive expenses associated with our synergy program;
- legal reserve and costs associated with significant legal and regulatory matters; and
- asset impairment.
We calculate adjusted EBITDA margin by dividing adjusted EBITDA by adjusted revenue.
Adjusted Net Income
We define adjusted net income as net income (loss) attributable to
- incremental amortization resulting from the application of purchase accounting. We exclude amortization of recognized intangible assets resulting from the application of purchase accounting because it is non-cash and is not indicative of our ongoing and underlying operating performance. The Company believes that recognized intangible assets by their nature are fundamentally different from other depreciating assets that are replaced on a predictable operating cycle. Unlike other depreciating assets, such as developed and purchased software licenses or property and equipment, there is no replacement cost once these recognized intangible assets expire and the assets are not replaced. Additionally, the Company’s costs to operate, maintain and extend the life of acquired intangible assets and purchased intellectual property are reflected in the Company’s operating costs as personnel, data fee, facilities, overhead and similar items;
- other incremental or reduced expenses and revenue from the application of purchase accounting (e.g. commission asset amortization) and acquisitions;
- equity-based compensation;
- restructuring charges;
- merger and acquisition-related operating costs;
- transition costs primarily consisting of non-recurring incentive expenses associated with our synergy program;
- legal reserve and costs associated with significant legal and regulatory matters;
- change in fair value of the make-whole derivative liability associated with the Series A Preferred Stock;
- asset impairment;
- dividends allocated to preferred stockholders;
- merger, acquisition and divestiture-related non-operating costs;
- debt refinancing and extinguishment costs; and
- tax effect of the non-GAAP adjustments and the impact resulting from the enactment of the CARES Act.
Adjusted Net Earnings per Diluted Share
We calculate adjusted net earnings per diluted share by dividing adjusted net income (loss) by the weighted average number of common shares outstanding for the period plus the dilutive effect of common shares potentially issuable in connection with awards outstanding under our stock incentive plan.
Forward-Looking Statements
The statements contained in this release that are not purely historical are forward-looking statements, including statements regarding expectations, hopes, intentions or strategies regarding the future. Forward-looking statements are based on Dun & Bradstreet’s management’s beliefs, as well as assumptions made by, and information currently available to, them. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. It is not possible to predict or identify all risk factors. Consequently, the risks and uncertainties listed below should not be considered a complete discussion of all of our potential trends, risks and uncertainties. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
The risks and uncertainties that forward-looking statements are subject to include, but are not limited to: (i) an outbreak of disease, global or localized health pandemic or epidemic, or the fear of such an event (such as the COVID-19 global pandemic), including the global economic uncertainty and measures taken in response; (ii) the short- and long-term effects of the COVID-19 global pandemic, including the pace of recovery or any future resurgence; (iii) our ability to implement and execute our strategic plans to transform the business; (iv) our ability to develop or sell solutions in a timely manner or maintain client relationships; (v) competition for our solutions; (vi) harm to our brand and reputation; (vii) unfavorable global economic conditions; (viii) risks associated with operating and expanding internationally; (ix) failure to prevent cybersecurity incidents or the perception that confidential information is not secure; (x) failure in the integrity of our data or systems; (xi) system failures and personnel disruptions, which could delay the delivery of our solutions to our clients; (xii) loss of access to data sources or ability to transfer data across the data sources in markets we operate; (xiii) failure of our software vendors and network and cloud providers to perform as expected or if our relationship is terminated; (xiv) loss or diminution of one or more of our key clients, business partners or government contracts; (xv) dependence on strategic alliances, joint ventures and acquisitions to grow our business; (xvi) our ability to protect our intellectual property adequately or cost-effectively; (xvii) claims for intellectual property infringement; (xviii) interruptions, delays or outages to subscription or payment processing platforms; (xix) risks related to acquiring and integrating businesses and divestitures of existing businesses; (xx) our ability to retain members of the senior leadership team and attract and retain skilled employees; (xxi) compliance with governmental laws and regulations; (xxii) risks associated with our structure and status as a "controlled company;" and (xxiii) the other factors described under the headings “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note Regarding Forward-Looking Statements” and other sections of our Annual Report on Form 10-K and filed with the
Condensed Consolidated Statements of Operations (Amounts in millions, except per share data) (Unaudited) |
|||||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||||
|
2021 |
|
2020 (1) |
|
2021 |
|
2020 (1) |
||||||||||
Revenue |
$ |
541.9 |
|
|
$ |
444.4 |
|
|
$ |
1,567.3 |
|
|
$ |
1,258.8 |
|
||
Operating expenses |
159.4 |
|
|
128.5 |
|
|
487.6 |
|
|
403.9 |
|
||||||
Selling and administrative expenses |
171.5 |
|
|
131.7 |
|
|
515.6 |
|
|
401.2 |
|
||||||
Depreciation and amortization |
156.7 |
|
|
134.3 |
|
|
458.7 |
|
|
401.4 |
|
||||||
Restructuring charges |
4.8 |
|
|
4.4 |
|
|
20.7 |
|
|
16.3 |
|
||||||
Operating costs |
492.4 |
|
|
398.9 |
|
|
1,482.6 |
|
|
1,222.8 |
|
||||||
Operating income (loss) |
49.5 |
|
|
45.5 |
|
|
84.7 |
|
|
36.0 |
|
||||||
Interest income |
0.2 |
|
|
0.1 |
|
|
0.5 |
|
|
0.6 |
|
||||||
Interest expense |
(48.3 |
) |
|
(60.8 |
) |
|
(145.2 |
) |
|
(221.8 |
) |
||||||
Other income (expense) - net |
13.3 |
|
|
(8.8 |
) |
|
32.5 |
|
|
(42.4 |
) |
||||||
Non-operating income (expense) - net |
(34.8 |
) |
|
(69.5 |
) |
|
(112.2 |
) |
|
(263.6 |
) |
||||||
Income (loss) before provision (benefit) for income taxes and equity in net income of affiliates |
14.7 |
|
|
(24.0 |
) |
|
(27.5 |
) |
|
(227.6 |
) |
||||||
Less: provision (benefit) for income taxes |
(2.8 |
) |
|
(9.1 |
) |
|
30.4 |
|
|
(111.0 |
) |
||||||
Equity in net income of affiliates |
0.7 |
|
|
0.6 |
|
|
2.0 |
|
|
1.9 |
|
||||||
Net income (loss) |
18.2 |
|
|
(14.3 |
) |
|
(55.9 |
) |
|
(114.7 |
) |
||||||
Less: net (income) loss attributable to the non-controlling interest |
(1.6 |
) |
|
(2.0 |
) |
|
(4.2 |
) |
|
(3.6 |
) |
||||||
Less: Dividends allocated to preferred stockholders |
— |
|
|
— |
|
|
— |
|
|
(64.1 |
) |
||||||
Net income (loss) attributable to |
$ |
16.6 |
|
|
$ |
(16.3 |
) |
|
$ |
(60.1 |
) |
|
$ |
(182.4 |
) |
||
|
|
|
|
|
|
|
|
||||||||||
Basic earnings (loss) per share of common stock attributable to |
$ |
0.04 |
|
|
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
$ |
(0.52 |
) |
||
Diluted earnings (loss) per share of common stock attributable to |
$ |
0.04 |
|
|
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
$ |
(0.52 |
) |
||
Weighted average number of shares outstanding-basic |
428.6 |
|
415.7 |
|
|
428.7 |
|
348.5 |
|
||||||||
Weighted average number of shares outstanding-diluted |
428.7 |
|
415.7 |
|
|
428.7 |
|
348.5 |
|
(1) |
Revised to reflect the elimination of the international lag reporting. See further details in Note 1 to the condensed consolidated financial statements for the three and nine months ended |
Condensed Consolidated Balance Sheets (Amounts in millions, except share data and per share data) (Unaudited) |
|||||||
|
|
|
2020 (1) |
||||
Assets |
|
|
|
||||
Current assets |
|
|
|
||||
Cash and cash equivalents |
$ |
234.4 |
|
|
$ |
352.3 |
|
Accounts receivable, net of allowance of |
285.2 |
|
|
319.3 |
|
||
Other receivables |
9.7 |
|
|
7.5 |
|
||
Prepaid taxes |
55.4 |
|
|
130.4 |
|
||
Other prepaids |
60.5 |
|
|
37.9 |
|
||
Other current assets |
3.8 |
|
|
27.0 |
|
||
Total current assets |
649.0 |
|
|
874.4 |
|
||
Non-current assets |
|
|
|
||||
Property, plant and equipment, net of accumulated depreciation of |
97.9 |
|
|
25.7 |
|
||
Computer software, net of accumulated amortization of |
525.6 |
|
|
437.0 |
|
||
|
3,318.7 |
|
|
2,857.9 |
|
||
Deferred income tax |
16.4 |
|
|
14.1 |
|
||
Other intangibles |
4,909.9 |
|
|
4,814.8 |
|
||
Deferred costs |
97.7 |
|
|
83.8 |
|
||
Other non-current assets |
132.1 |
|
|
112.6 |
|
||
Total non-current assets |
9,098.3 |
|
|
8,345.9 |
|
||
Total assets |
$ |
9,747.3 |
|
|
$ |
9,220.3 |
|
Liabilities |
|
|
|
||||
Current liabilities |
|
|
|
||||
Accounts payable |
$ |
65.1 |
|
|
$ |
60.1 |
|
Accrued payroll |
102.5 |
|
|
110.5 |
|
||
Accrued income tax |
18.6 |
|
|
3.9 |
|
||
Short-term debt |
28.1 |
|
|
25.3 |
|
||
Other accrued and current liabilities |
149.7 |
|
|
151.1 |
|
||
Deferred revenue |
555.6 |
|
|
477.2 |
|
||
Total current liabilities |
919.6 |
|
|
828.1 |
|
||
Long-term pension and postretirement benefits |
308.1 |
|
|
291.5 |
|
||
Long-term debt |
3,543.5 |
|
|
3,255.8 |
|
||
Liabilities for unrecognized tax benefits |
18.1 |
|
|
18.9 |
|
||
Deferred income tax |
1,183.6 |
|
|
1,106.6 |
|
||
Other non-current liabilities |
129.1 |
|
|
135.5 |
|
||
Total liabilities |
6,102.0 |
|
|
5,636.4 |
|
||
Commitments and contingencies |
|
|
|
||||
|
|
|
|
||||
Equity |
|
|
|
||||
Common Stock, |
— |
|
|
— |
|
||
Capital surplus |
4,491.0 |
|
|
4,310.1 |
|
||
Accumulated deficit |
(754.0 |
) |
|
(693.9 |
) |
||
Treasury Stock, 873,217 shares at |
(0.3 |
) |
|
— |
|
||
Accumulated other comprehensive loss |
(153.5 |
) |
|
(90.6 |
) |
||
Total stockholder equity |
3,583.2 |
|
|
3,525.6 |
|
||
Non-controlling interest |
62.1 |
|
|
58.3 |
|
||
Total equity |
3,645.3 |
|
|
3,583.9 |
|
||
Total liabilities and stockholder equity |
$ |
9,747.3 |
|
|
$ |
9,220.3 |
|
(1) |
Revised to reflect the elimination of the international lag reporting. See further details in Note 1 to the condensed consolidated financial statements for the three and nine months ended |
Condensed Consolidated Statements of Cash Flows (Tabular amounts in millions) (Unaudited) |
||||||||
|
Nine months ended |
|||||||
|
2021 |
|
2020 (1) |
|||||
Cash flows provided by (used in) operating activities: |
|
|
|
|||||
Net income (loss) |
$ |
(55.9 |
) |
|
$ |
(114.7 |
) |
|
Reconciliation of net income (loss) to net cash provided by (used in) operating activities: |
|
|
|
|||||
Depreciation and amortization |
458.7 |
|
|
401.4 |
|
|||
Amortization of unrecognized pension loss (gain) |
1.4 |
|
|
(0.3 |
) |
|||
Equity-based compensation expense |
23.7 |
|
|
38.6 |
|
|||
Restructuring charge |
20.7 |
|
|
16.3 |
|
|||
Restructuring payments |
(13.5 |
) |
|
(13.6 |
) |
|||
Change in fair value of make-whole derivative liability |
— |
|
|
32.8 |
|
|||
Changes in deferred income taxes |
(48.7 |
) |
|
(100.6 |
) |
|||
Changes in prepaid and accrued income taxes |
7.2 |
|
|
(95.6 |
) |
|||
Changes in operating assets and liabilities: (3) |
|
|
|
|||||
(Increase) decrease in accounts receivable |
88.9 |
|
|
26.1 |
|
|||
(Increase) decrease in other current assets |
62.5 |
|
|
(11.6 |
) |
|||
Increase (decrease) in deferred revenue |
2.5 |
|
|
5.3 |
|
|||
Increase (decrease) in accounts payable |
(12.8 |
) |
|
6.4 |
|
|||
Increase (decrease) in accrued liabilities |
(55.2 |
) |
|
0.3 |
|
|||
Increase (decrease) in other accrued and current liabilities |
(23.9 |
) |
|
(35.8 |
) |
|||
(Increase) decrease in other long-term assets |
(10.3 |
) |
|
(34.8 |
) |
|||
Increase (decrease) in long-term liabilities |
(63.7 |
) |
|
(22.6 |
) |
|||
Net, other non-cash adjustments (2) |
19.6 |
|
|
33.1 |
|
|||
Net cash provided by (used in) operating activities |
401.2 |
|
|
130.7 |
|
|||
Cash flows provided by (used in) investing activities: |
|
|
|
|||||
Acquisitions of businesses, net of cash acquired (5) |
(617.0 |
) |
|
(20.6 |
) |
|||
Cash settlements of foreign currency contracts |
22.8 |
|
|
1.3 |
|
|||
Payments for real estate purchase |
(76.6 |
) |
|
— |
|
|||
Capital expenditures |
(8.2 |
) |
|
(8.1 |
) |
|||
Additions to computer software and other intangibles (4) |
(112.3 |
) |
|
(85.3 |
) |
|||
Other investing activities, net |
0.6 |
|
|
0.4 |
|
|||
Net cash provided by (used in) investing activities |
(790.7 |
) |
|
(112.3 |
) |
|||
Cash flows provided by (used in) financing activities: |
|
|
|
|||||
Proceeds from issuance of common stock in the IPO transaction and Private Placement, net |
— |
|
|
2,248.2 |
|
|||
Payment for the redemption of Cumulative Series A Preferred Stock |
— |
|
|
(1,067.8 |
) |
|||
Payment for make-whole liability |
— |
|
|
(205.2 |
) |
|||
Payment for debt early redemption premiums |
— |
|
|
(50.0 |
) |
|||
Payments of dividends |
— |
|
|
(64.1 |
) |
|||
Proceeds from borrowings on Credit Facility |
64.1 |
|
|
407.2 |
|
|||
Proceeds from borrowings on Term Loan Facilities |
300.0 |
|
|
— |
|
|||
Payments of borrowings on Credit Facility |
(64.1 |
) |
|
(407.2 |
) |
|||
Payments of borrowing on Term Loan Facility |
(21.1 |
) |
|
(12.7 |
) |
|||
Payments of borrowings on Successor’s Senior Notes |
— |
|
|
(580.0 |
) |
|||
Payments of borrowings on |
— |
|
|
(63.0 |
) |
|||
Payment of debt issuance costs |
(2.6 |
) |
|
(2.5 |
) |
|||
Other financing activities, net |
(2.2 |
) |
|
(6.7 |
) |
|||
Net cash provided by (used in) financing activities |
274.1 |
|
|
196.2 |
|
|||
Effect of exchange rate changes on cash and cash equivalents |
(2.5 |
) |
|
0.5 |
|
|||
Increase (decrease) in cash and cash equivalents |
(117.9 |
) |
|
215.1 |
|
|||
Cash and Cash Equivalents, Beginning of Period |
352.3 |
|
|
84.4 |
|
|||
Cash and Cash Equivalents, End of Period |
$ |
234.4 |
|
|
$ |
299.5 |
|
|
Supplemental Disclosure of Cash Flow Information: |
|
|
|
|||||
Cash Paid for: |
|
|
|
|||||
Income taxes payment (refund), net |
$ |
(2.4 |
) |
|
$ |
85.2 |
|
|
Interest |
$ |
149.7 |
|
|
$ |
223.1 |
|
(1) |
Revised to reflect the elimination of the international lag reporting. See further details in Note 1 to the condensed consolidated financial statements for the three and nine months ended |
(2) |
Primarily includes non-cash amortization of deferred debt issuance cost and discount of |
(3) |
Net of the effect of acquisitions. |
(4) |
Non-cash investment of |
(5) |
In connection with the |
Reconciliation of GAAP to Non-GAAP Financial Measures (Unaudited) (Amounts in millions) |
|||||||||||||||
Reconciliation of Revenue to Adjusted Revenue and Organic Revenue |
|||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Revenue |
$ |
541.9 |
|
|
$ |
444.4 |
|
|
$ |
1,567.3 |
|
|
$ |
1,258.8 |
|
Revenue adjustment due to the |
— |
|
|
— |
|
|
4.6 |
|
|
— |
|
||||
Adjusted revenue (a) |
541.9 |
|
|
444.4 |
|
|
1,571.9 |
|
|
1,258.8 |
|
||||
Foreign currency impact |
1.1 |
|
|
0.6 |
|
|
(1.5 |
) |
|
5.5 |
|
||||
Adjusted revenue before the effect of foreign currency (a) |
$ |
543.0 |
|
|
$ |
445.0 |
|
|
$ |
1,570.4 |
|
|
$ |
1,264.3 |
|
Net revenue from |
(80.5 |
) |
|
— |
|
|
(252.2 |
) |
|
— |
|
||||
Organic revenue - before the effect of foreign currency (a) |
$ |
462.5 |
|
|
$ |
445.0 |
|
|
$ |
1,318.2 |
|
|
$ |
1,264.3 |
|
|
|
|
|
|
|
|
|
||||||||
|
$ |
374.1 |
|
|
$ |
363.0 |
|
|
$ |
1,070.7 |
|
|
$ |
1,058.9 |
|
International |
167.8 |
|
|
82.4 |
|
|
501.4 |
|
|
220.4 |
|
||||
Segment revenue |
$ |
541.9 |
|
|
$ |
445.4 |
|
|
$ |
1,572.1 |
|
|
$ |
1,279.3 |
|
Corporate and other (a) |
— |
|
|
(1.0 |
) |
|
(0.2 |
) |
|
(20.5 |
) |
||||
Foreign currency impact |
1.1 |
|
|
0.6 |
|
|
(1.5 |
) |
|
5.5 |
|
||||
Adjusted revenue before the effect of foreign currency (a) |
$ |
543.0 |
|
|
$ |
445.0 |
|
|
$ |
1,570.4 |
|
|
$ |
1,264.3 |
|
Net revenue from |
(80.5 |
) |
|
— |
|
|
(252.2 |
) |
|
— |
|
||||
Organic revenue - before the effect of foreign currency (a) |
$ |
462.5 |
|
|
$ |
445.0 |
|
|
$ |
1,318.2 |
|
|
$ |
1,264.3 |
|
|
|
|
|
|
|
|
|
||||||||
(a) Includes deferred revenue purchase accounting adjustments |
$ |
— |
|
|
$ |
(1.0 |
) |
|
$ |
(0.2 |
) |
|
$ |
(20.5 |
) |
Reconciliation of Net Income (Loss) to Adjusted EBITDA |
|||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income (loss) attributable to |
$ |
16.6 |
|
|
$ |
(16.3 |
) |
|
$ |
(60.1 |
) |
|
$ |
(182.4 |
) |
Depreciation and amortization |
156.7 |
|
|
134.3 |
|
|
458.7 |
|
|
401.4 |
|
||||
Interest expense - net |
48.1 |
|
|
60.7 |
|
|
144.7 |
|
|
221.2 |
|
||||
(Benefit) provision for income tax - net |
(2.8 |
) |
|
(9.1 |
) |
|
30.4 |
|
|
(111.0 |
) |
||||
EBITDA |
218.6 |
|
|
169.6 |
|
|
573.7 |
|
|
329.2 |
|
||||
Other income (expense) - net |
(13.3 |
) |
|
8.8 |
|
|
(32.5 |
) |
|
42.4 |
|
||||
Equity in net income of affiliates |
(0.7 |
) |
|
(0.6 |
) |
|
(2.0 |
) |
|
(1.9 |
) |
||||
Net income (loss) attributable to non-controlling interest |
1.6 |
|
|
2.0 |
|
|
4.2 |
|
|
3.6 |
|
||||
Dividends allocated to preferred stockholders |
— |
|
|
— |
|
|
— |
|
|
64.1 |
|
||||
Other incremental or reduced expenses and revenue from the application of purchase accounting and acquisitions |
(4.0 |
) |
|
(4.6 |
) |
|
(8.9 |
) |
|
(14.4 |
) |
||||
Equity-based compensation |
9.0 |
|
|
9.7 |
|
|
23.7 |
|
|
38.6 |
|
||||
Restructuring charges |
4.8 |
|
|
4.4 |
|
|
20.7 |
|
|
16.3 |
|
||||
Merger and acquisition-related operating costs |
2.1 |
|
|
2.3 |
|
|
7.2 |
|
|
6.7 |
|
||||
Transition costs |
1.7 |
|
|
4.4 |
|
|
5.6 |
|
|
22.3 |
|
||||
Legal reserve associated with significant legal and regulatory matters |
0.5 |
|
|
— |
|
|
11.1 |
|
|
— |
|
||||
Asset impairment |
0.1 |
|
|
0.3 |
|
|
1.6 |
|
|
0.6 |
|
||||
Adjusted EBITDA |
$ |
220.4 |
|
|
$ |
196.3 |
|
|
$ |
604.4 |
|
|
$ |
507.5 |
|
|
|
|
|
|
|
|
|
||||||||
|
$ |
185.5 |
|
|
$ |
183.7 |
|
|
$ |
504.0 |
|
|
$ |
498.6 |
|
International |
54.0 |
|
|
28.0 |
|
|
148.1 |
|
|
72.0 |
|
||||
Corporate and other (a) |
(19.1 |
) |
|
(15.4 |
) |
|
(47.7 |
) |
|
(63.1 |
) |
||||
Adjusted EBITDA (a) |
$ |
220.4 |
|
|
$ |
196.3 |
|
|
$ |
604.4 |
|
|
$ |
507.5 |
|
Adjusted EBITDA Margin (a) |
40.7 |
% |
|
44.2 |
% |
|
38.5 |
% |
|
40.3 |
% |
||||
(a) Including impact of deferred revenue purchase accounting adjustments: |
|
|
|
|
|
|
|
||||||||
Impact to adjusted EBITDA |
$ |
— |
|
|
$ |
(1.0 |
) |
|
$ |
(0.2 |
) |
|
$ |
(20.5 |
) |
Impact to adjusted EBITDA margin |
— |
% |
|
(0.1 |
)% |
|
— |
% |
|
(1.0 |
)% |
Segment Revenue and Adjusted EBITDA (Unaudited) (Amounts in millions) |
|||||||||||||||
|
Three months ended |
||||||||||||||
|
|
|
International |
|
Corporate and Other (a) |
|
Total |
||||||||
Adjusted revenue |
$ |
374.1 |
|
|
$ |
167.8 |
|
|
$ |
— |
|
|
$ |
541.9 |
|
Total operating costs |
205.2 |
|
|
117.0 |
|
|
21.0 |
|
|
343.2 |
|
||||
Operating income (loss) |
168.9 |
|
|
50.8 |
|
|
(21.0 |
) |
|
198.7 |
|
||||
Depreciation and amortization |
16.6 |
|
|
3.2 |
|
|
1.9 |
|
|
21.7 |
|
||||
Adjusted EBITDA |
$ |
185.5 |
|
|
$ |
54.0 |
|
|
$ |
(19.1 |
) |
|
$ |
220.4 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA margin |
49.6 |
% |
|
32.2 |
% |
|
N/A |
|
40.7 |
% |
|||||
|
Nine months ended |
||||||||||||||
|
|
|
International |
|
Corporate and Other (a) |
|
Total |
||||||||
Adjusted revenue |
$ |
1,070.7 |
|
|
$ |
501.4 |
|
|
$ |
(0.2 |
) |
|
$ |
1,571.9 |
|
Total operating costs |
610.5 |
|
|
362.1 |
|
|
53.5 |
|
|
1,026.1 |
|
||||
Operating income (loss) |
460.2 |
|
|
139.3 |
|
|
(53.7 |
) |
|
545.8 |
|
||||
Depreciation and amortization |
43.8 |
|
|
8.8 |
|
|
6.0 |
|
|
58.6 |
|
||||
Adjusted EBITDA |
$ |
504.0 |
|
|
$ |
148.1 |
|
|
$ |
(47.7 |
) |
|
$ |
604.4 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA margin |
47.1 |
% |
|
29.5 |
% |
|
N/A |
|
38.5 |
% |
|||||
|
Three months ended |
||||||||||||||
|
|
|
International |
|
Corporate and Other (a) |
|
Total |
||||||||
Adjusted revenue |
$ |
363.0 |
|
|
$ |
82.4 |
|
|
$ |
(1.0 |
) |
|
$ |
444.4 |
|
Total operating costs |
191.2 |
|
|
56.6 |
|
|
16.4 |
|
|
264.2 |
|
||||
Operating income (loss) |
171.8 |
|
|
25.8 |
|
|
(17.4 |
) |
|
180.2 |
|
||||
Depreciation and amortization |
11.9 |
|
|
2.2 |
|
|
2.0 |
|
|
16.1 |
|
||||
Adjusted EBITDA |
$ |
183.7 |
|
|
$ |
28.0 |
|
|
$ |
(15.4 |
) |
|
$ |
196.3 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA margin |
50.6 |
% |
|
34.0 |
% |
|
N/A |
|
44.2 |
% |
|||||
|
Nine months ended |
||||||||||||||
|
|
|
International |
|
Corporate and Other (a) |
|
Total |
||||||||
Adjusted revenue |
$ |
1,058.9 |
|
|
$ |
220.4 |
|
|
$ |
(20.5 |
) |
|
$ |
1,258.8 |
|
Total operating costs |
594.2 |
|
|
154.3 |
|
|
48.4 |
|
|
796.9 |
|
||||
Operating income (loss) |
464.7 |
|
|
66.1 |
|
|
(68.9 |
) |
|
461.9 |
|
||||
Depreciation and amortization |
33.9 |
|
|
5.9 |
|
|
5.8 |
|
|
45.6 |
|
||||
Adjusted EBITDA |
$ |
498.6 |
|
|
$ |
72.0 |
|
|
$ |
(63.1 |
) |
|
$ |
507.5 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA margin |
47.1 |
% |
|
32.7 |
% |
|
N/A |
|
40.3 |
% |
|||||
(a) Includes deferred revenue purchase accounting adjustments. |
Reconciliation of GAAP to Non-GAAP Financial Measures (Unaudited) (Amounts in millions) |
|||||||||||||||
Reconciliation of Net Income (Loss) to Adjusted Net Income (Loss) |
|||||||||||||||
|
Three months ended |
|
Nine months ended |
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income (loss) attributable to |
$ |
16.6 |
|
|
$ |
(16.3 |
) |
|
$ |
(60.1 |
) |
|
$ |
(182.4 |
) |
Dividends allocated to preferred stockholders |
— |
|
|
— |
|
|
— |
|
|
64.1 |
|
||||
Incremental amortization of intangible assets resulting from the application of purchase accounting |
135.0 |
|
|
118.2 |
|
|
400.1 |
|
|
355.8 |
|
||||
Other incremental or reduced expenses and revenue from the application of purchase accounting and acquisitions |
(4.0 |
) |
|
(4.6 |
) |
|
(8.9 |
) |
|
(14.4 |
) |
||||
Equity-based compensation |
9.0 |
|
|
9.7 |
|
|
23.7 |
|
|
38.6 |
|
||||
Restructuring charges |
4.8 |
|
|
4.4 |
|
|
20.7 |
|
|
16.3 |
|
||||
Merger and acquisition-related operating costs |
2.1 |
|
|
2.3 |
|
|
7.2 |
|
|
6.7 |
|
||||
Transition costs |
1.7 |
|
|
4.4 |
|
|
5.6 |
|
|
22.3 |
|
||||
Legal expense and costs associated with significant legal and regulatory matters |
0.5 |
|
|
— |
|
|
11.1 |
|
|
— |
|
||||
Change in fair value of make-whole derivative liability |
— |
|
|
— |
|
|
— |
|
|
32.8 |
|
||||
Asset impairment |
0.1 |
|
|
0.3 |
|
|
1.6 |
|
|
0.6 |
|
||||
Merger and acquisition-related non-operating costs |
— |
|
|
— |
|
|
2.3 |
|
|
— |
|
||||
Debt refinancing and extinguishment costs |
— |
|
|
25.8 |
|
|
1.1 |
|
|
74.1 |
|
||||
Tax impact of the CARES Act |
(0.1 |
) |
|
(4.1 |
) |
|
(0.8 |
) |
|
(57.8 |
) |
||||
Tax effect of the non-GAAP adjustments |
(42.3 |
) |
|
(38.9 |
) |
|
(74.4 |
) |
|
(124.8 |
) |
||||
Adjusted net income (loss) attributable to |
$ |
123.4 |
|
|
$ |
101.2 |
|
|
$ |
329.2 |
|
|
$ |
231.9 |
|
Adjusted diluted earnings (loss) per share of common stock |
$ |
0.29 |
|
|
$ |
0.24 |
|
|
$ |
0.77 |
|
|
$ |
0.67 |
|
Weighted average number of shares outstanding - diluted |
428.7 |
|
|
416.3 |
|
|
428.8 |
|
|
348.6 |
|
||||
|
|
|
|
|
|
|
|
||||||||
(a) Including impact of deferred revenue purchase accounting adjustments: |
|
|
|
|
|
|
|
||||||||
Pre-tax impact |
$ |
— |
|
|
$ |
(1.0 |
) |
|
$ |
(0.2 |
) |
|
$ |
(20.5 |
) |
Tax impact |
— |
|
|
0.3 |
|
|
— |
|
|
5.3 |
|
||||
Net impact to adjusted net income (loss) attributable to |
$ |
— |
|
|
$ |
(0.7 |
) |
|
$ |
(0.2 |
) |
|
$ |
(15.2 |
) |
Net impact to adjusted diluted earnings (loss) per share of common stock |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(0.04 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005334/en/
Media Contact:
973-921-6263
KwongL@dnb.com
Investor Contact:
973-921-6008
IR@dnb.com
Source:
FAQ
What were Dun & Bradstreet's Q3 2021 earnings results?
How did Dun & Bradstreet perform in terms of organic revenue growth?
What is Dun & Bradstreet's adjusted EPS outlook for 2021?